T-Cypher Bio

T-Cypher Bio develops innovative drugs with curative potential, focusing on immune system engaging medicines for cancer and autoimmune diseases

Biotech & Life Sciences

Sector

Seed

Stage

Biotechnology

Model

01Company Overview

T-Cypher Bio develops innovative drugs with curative potential, focusing on immune system engaging medicines for cancer and autoimmune diseases. They leverage novel disease-specific targets and proprietary platform technologies to enhance immune functionality and improve patient outcomes.

02Backed By1 investor

MMedicxi→

03Similar Companies

Is this your company? Claim your profile